Loading...

DYN DYNE THERAPEUTICS INC Operational Disruptions 8-K Filing

DYN

DYN

DYNE THERAPEUTICS INC

(DYN)

2024 8-K

Show Summary

Show Summary

Accelerated Approval Pathway

Financial Statements

Management Change

Financial Results

Financial Update

Financial Results

Leadership Changes

Financial Results

Annual Meeting of Stockholders

Public Offering

Clinical Trial Results

Financial Results Announcement

Appointment of President an...

Financial Results Announcement

Public Offering

Suspension of Prospectus

Clinical Trial Results

Financial Results Announcement

Financial Results Announcement

Departure of Directors

Financial Results Announcement

Regulation FD Disclosure

Financial Results Announcement

External Links:

Dyne Therapeutics announced positive clinical data from its ongoing Phase 1/2 ACHIEVE and DELIVER trials for DYNE-101 and DYNE-251, respectively, in patients with myotonic dystrophy type 1 and Duchenne muscular dystrophy.

AI Assistant

DYNE THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.